{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T05:11:49Z","timestamp":1780117909141,"version":"3.54.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T00:00:00Z","timestamp":1578009600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.ebiom.2020.102628","type":"journal-article","created":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T06:12:46Z","timestamp":1579673566000},"page":"102628","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Informatics-guided drug repurposing for Autosomal Dominant Polycystic Kidney Disease (ADPKD)"],"prefix":"10.1016","volume":"52","author":[{"given":"Anna A.","family":"Kiseleva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica A.","family":"Golemis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10174","key":"10.1016\/j.ebiom.2020.102628_bib0001","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0140-6736(18)32782-X","article-title":"Autosomal dominant polycystic kidney disease","volume":"393","author":"Cornec-Le Gall","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102628_bib0002","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.kint.2017.12.026","article-title":"Drug repurposing in kidney disease","volume":"94","author":"Panchapakesan","year":"2018","journal-title":"Kidney Int"},{"issue":"9","key":"10.1016\/j.ebiom.2020.102628_bib0003","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/nrneph.2015.46","article-title":"The hallmarks of cancer: relevance to the pathogenesis of polycystic kidney disease","volume":"11","author":"Seeger-Nukpezah","year":"2015","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"10.1016\/j.ebiom.2020.102628_bib0004","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1096\/fj.201700909R","article-title":"Ganetespib limits ciliation and cystogenesis in autosomal-dominant polycystic kidney disease (ADPKD)","volume":"32","author":"Nikonova","year":"2018","journal-title":"FASEB J"},{"issue":"7","key":"10.1016\/j.ebiom.2020.102628_bib0005","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1681\/ASN.2007060665","article-title":"Src inhibition ameliorates polycystic kidney disease","volume":"19","author":"Sweeney","year":"2008","journal-title":"J Am Soc Nephrol"},{"issue":"14","key":"10.1016\/j.ebiom.2020.102628_bib0006","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1073\/pnas.0509694103","article-title":"The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease","volume":"103","author":"Shillingford","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ebiom.2020.102628_bib0007","doi-asserted-by":"crossref","unstructured":"Malas T., Leonhard W., Bange H. et al. Prioritization of novel adpkd drug candidates from disease-stage specific gene expression profiles. EBioMedicine.Access available at DOI: 10.1016\/j.ebiom.2019.11.046","DOI":"10.1016\/j.ebiom.2019.11.046"},{"key":"10.1016\/j.ebiom.2020.102628_bib0008","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.gene.2017.06.059","article-title":"Profiling conserved biological pathways in Autosomal Dominant Polycystic Kidney Disorder (ADPKD) to elucidate key transcriptomic alterations regulating cystogenesis: a cross-species meta-analysis approach","volume":"627","author":"Chatterjee","year":"2017","journal-title":"Gene"},{"issue":"3","key":"10.1016\/j.ebiom.2020.102628_bib0009","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.ygeno.2004.03.009","article-title":"New insights into adpkd molecular pathways using combination of sage and microarray technologies","volume":"84","author":"Husson","year":"2004","journal-title":"Genomics"},{"issue":"4","key":"10.1016\/j.ebiom.2020.102628_bib0010","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1053\/j.gastro.2017.06.008","article-title":"Colorectal cancer cell line proteomes are representative of primary tumors and predict drug sensitivity","volume":"153","author":"Wang","year":"2017","journal-title":"Gastroenterology"}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396420300037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396420300037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:55:41Z","timestamp":1762455341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396420300037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":10,"alternative-id":["S2352396420300037"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2020.102628","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Informatics-guided drug repurposing for Autosomal Dominant Polycystic Kidney Disease (ADPKD)","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2020.102628","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2019.11.046","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102628"}}